Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 462.84 million. The enterprise value is 600.48 million.

Market Cap	462.84M
Enterprise Value	600.48M

Important Dates

The next confirmed earnings date is Friday, August 14, 2026.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 23.98 million shares outstanding. The number of shares has increased by 15.96% in one year.

Current Share Class	23.98M
Shares Outstanding	23.98M
Shares Change (YoY)	+15.96%
Shares Change (QoQ)	-2.42%
Owned by Insiders (%)	10.75%
Owned by Institutions (%)	31.17%
Float	20.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	90.82
PS Ratio	0.81
PB Ratio	1.48
P/TBV Ratio	n/a
P/FCF Ratio	39.07
P/OCF Ratio	32.57
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.70, with an EV/FCF ratio of 50.69.

EV / Earnings	-37.06
EV / Sales	1.05
EV / EBITDA	12.70
EV / EBIT	67.38
EV / FCF	50.69

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.65.

Current Ratio	1.47
Quick Ratio	0.76
Debt / Equity	0.65
Debt / EBITDA	4.33
Debt / FCF	17.28
Interest Coverage	0.52

Financial Efficiency

Return on equity (ROE) is -6.15% and return on invested capital (ROIC) is 1.94%.

Return on Equity (ROE)	-6.15%
Return on Assets (ROA)	0.95%
Return on Invested Capital (ROIC)	1.94%
Return on Capital Employed (ROCE)	1.70%
Weighted Average Cost of Capital (WACC)	5.84%
Revenue Per Employee	15.03M
Profits Per Employee	-426,342
Employee Count	38
Asset Turnover	0.97
Inventory Turnover	3.45

Taxes

In the past 12 months, Navamedic ASA has paid 4.99 million in taxes.

Income Tax	4.99M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.86% in the last 52 weeks. The beta is 0.23, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	-9.86%
50-Day Moving Average	20.45
200-Day Moving Average	22.04
Relative Strength Index (RSI)	41.59
Average Volume (20 Days)	15,274

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 571.24 million and -16.20 million in losses. Loss per share was -0.79.

Revenue	571.24M
Gross Profit	218.22M
Operating Income	8.91M
Pretax Income	-11.21M
Net Income	-16.20M
EBITDA	44.25M
EBIT	8.91M
Loss Per Share	-0.79

Full Income Statement

Balance Sheet

The company has 67.10 million in cash and 204.74 million in debt, giving a net cash position of -137.64 million or -5.74 per share.

Cash & Cash Equivalents	67.10M
Total Debt	204.74M
Net Cash	-137.64M
Net Cash Per Share	-5.74
Equity (Book Value)	312.90M
Book Value Per Share	13.37
Working Capital	77.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.21 million and capital expenditures -2.37 million, giving a free cash flow of 11.85 million.

Operating Cash Flow	14.21M
Capital Expenditures	-2.37M
Depreciation & Amortization	35.34M
Net Borrowing	89.96M
Free Cash Flow	11.85M
FCF Per Share	0.49

Full Cash Flow Statement

Margins

Gross margin is 38.20%, with operating and profit margins of 1.56% and -2.84%.

Gross Margin	38.20%
Operating Margin	1.56%
Pretax Margin	-1.96%
Profit Margin	-2.84%
EBITDA Margin	7.75%
EBIT Margin	1.56%
FCF Margin	2.07%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.96%
Shareholder Yield	-15.96%
Earnings Yield	-3.50%
FCF Yield	2.56%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Navamedic ASA has an Altman Z-Score of 1.69 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	4